Quarterly Consolidated Balance Sheet

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7737016

Concept As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2013-12-31
As at
2013-12-31
As at
2013-12-31
As at
2013-12-31
As at
2013-12-31
As at
2013-12-31
As at
2013-12-31
As at
2013-12-31
As at
2013-12-31
As at
2013-12-31
As at
2013-12-31
As at
2013-12-31
As at
2013-12-31
As at
2013-12-31
As at
2013-12-31
Quarterly consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
76,333,000,000 JPY
91,439,000,000 JPY
Securities
120,996,000,000 JPY
98,996,000,000 JPY
Merchandise and finished goods
68,058,000,000 JPY
69,634,000,000 JPY
Raw materials and supplies
36,072,000,000 JPY
21,009,000,000 JPY
Other
7,749,000,000 JPY
4,429,000,000 JPY
Current assets
531,973,000,000 JPY
496,139,000,000 JPY
Non-current assets
Property, plant and equipment
44,205,000,000 JPY
47,838,000,000 JPY
Property, plant and equipment
Land
9,147,000,000 JPY
9,147,000,000 JPY
Leased assets
Leased assets, net
5,000,000 JPY
4,000,000 JPY
Construction in progress
494,000,000 JPY
1,597,000,000 JPY
Intangible assets
Other
1,210,000,000 JPY
642,000,000 JPY
Intangible assets
1,811,000,000 JPY
891,000,000 JPY
Investments and other assets
92,001,000,000 JPY
89,476,000,000 JPY
Investments and other assets
Investment securities
12,839,000,000 JPY
9,856,000,000 JPY
Other
2,031,000,000 JPY
379,000,000 JPY
Allowance for doubtful accounts
-142,000,000 JPY
-148,000,000 JPY
Non-current assets
138,016,000,000 JPY
138,205,000,000 JPY
Assets
669,989,000,000 JPY
634,344,000,000 JPY
Liabilities
Current liabilities
Income taxes payable
13,052,000,000 JPY
16,531,000,000 JPY
Other
6,818,000,000 JPY
106,000,000 JPY
Current liabilities
119,998,000,000 JPY
113,488,000,000 JPY
Non-current liabilities
Asset retirement obligations
1,327,000,000 JPY
1,306,000,000 JPY
Other
209,000,000 JPY
49,000,000 JPY
Non-current liabilities
2,940,000,000 JPY
6,149,000,000 JPY
Liabilities
122,938,000,000 JPY
119,637,000,000 JPY
Net assets
Shareholders' equity
Share capital
72,967,000,000 JPY
72,967,000,000 JPY
Capital surplus
92,815,000,000 JPY
92,815,000,000 JPY
Retained earnings
407,515,000,000 JPY
376,793,000,000 JPY
Treasury shares
-31,935,000,000 JPY
-33,370,000,000 JPY
Shareholders' equity
541,363,000,000 JPY
509,205,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
5,787,000,000 JPY
3,936,000,000 JPY
Deferred gains or losses on hedges
-1,630,000,000 JPY
111,000,000 JPY
Valuation and translation adjustments
4,158,000,000 JPY
4,047,000,000 JPY
Share acquisition rights
1,530,000,000 JPY
1,455,000,000 JPY
Net assets
-31,935,000,000 JPY
6,480,000,000 JPY
149,220,000,000 JPY
72,967,000,000 JPY
251,091,000,000 JPY
4,158,000,000 JPY
-1,630,000,000 JPY
1,530,000,000 JPY
92,815,000,000 JPY
92,815,000,000 JPY
541,363,000,000 JPY
547,051,000,000 JPY
5,787,000,000 JPY
724,000,000 JPY
407,515,000,000 JPY
1,455,000,000 JPY
92,815,000,000 JPY
92,815,000,000 JPY
111,000,000 JPY
509,205,000,000 JPY
703,000,000 JPY
3,936,000,000 JPY
376,793,000,000 JPY
-33,370,000,000 JPY
6,480,000,000 JPY
514,707,000,000 JPY
72,967,000,000 JPY
220,390,000,000 JPY
4,047,000,000 JPY
149,220,000,000 JPY
490,158,000,000 JPY
7,579,000,000 JPY
4,163,000,000 JPY
92,815,000,000 JPY
481,154,000,000 JPY
719,000,000 JPY
3,417,000,000 JPY
-34,970,000,000 JPY
350,343,000,000 JPY
1,424,000,000 JPY
6,480,000,000 JPY
92,815,000,000 JPY
149,220,000,000 JPY
72,967,000,000 JPY
193,924,000,000 JPY
Liabilities and net assets
669,989,000,000 JPY
634,344,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.